Announcements

Quell Therapeutics and Cellistic™ enter a strategic collaboration to develop an iPSC-derived allogeneic T-regulatory (Treg) cell therapy platform

April 27, 2022

Quell Therapeutics and Cellistic™ enter a strategic collaboration to ...

– Collaboration combines Quell’s pioneering autologous multi-modular Treg cell therapy ...

Ncardia launches Cellistic™ — purpose-built to make large-scale allogeneic cell therapy production a reality today

April 18, 2022

Ncardia launches Cellistic™ — purpose-built to make large-scale allogeneic ...

Ncardia launches CellisticTM, the only iPSC-based cell therapy process development & ...

← 1 2 3